Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) HIV Diagnosis & Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global HIV Diagnosis & Treatment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 ELISA Test
      • 1.3.3 Saliva Tests
      • 1.3.4 Viral Load Test
      • 1.3.5 Western Blot
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global HIV Diagnosis & Treatment Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global HIV Diagnosis & Treatment Market Size
      • 2.1.1 Global HIV Diagnosis & Treatment Revenue 2014-2025
      • 2.1.2 Global HIV Diagnosis & Treatment Sales 2014-2025
    • 2.2 HIV Diagnosis & Treatment Growth Rate by Regions
      • 2.2.1 Global HIV Diagnosis & Treatment Sales by Regions 2014-2019
      • 2.2.2 Global HIV Diagnosis & Treatment Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 HIV Diagnosis & Treatment Sales by Manufacturers
      • 3.1.1 HIV Diagnosis & Treatment Sales by Manufacturers 2014-2019
      • 3.1.2 HIV Diagnosis & Treatment Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 HIV Diagnosis & Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 HIV Diagnosis & Treatment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global HIV Diagnosis & Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.3 HIV Diagnosis & Treatment Price by Manufacturers
    • 3.4 Key Manufacturers HIV Diagnosis & Treatment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into HIV Diagnosis & Treatment Market
    • 3.6 Key Manufacturers HIV Diagnosis & Treatment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 ELISA Test Sales and Revenue (2014-2019)
      • 4.1.2 Saliva Tests Sales and Revenue (2014-2019)
      • 4.1.3 Viral Load Test Sales and Revenue (2014-2019)
      • 4.1.4 Western Blot Sales and Revenue (2014-2019)
      • 4.1.5 Others Sales and Revenue (2014-2019)
    • 4.2 Global HIV Diagnosis & Treatment Sales Market Share by Type
    • 4.3 Global HIV Diagnosis & Treatment Revenue Market Share by Type
    • 4.4 HIV Diagnosis & Treatment Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global HIV Diagnosis & Treatment Sales by Application

    6 United States

    • 6.1 United States HIV Diagnosis & Treatment Breakdown Data by Company
    • 6.2 United States HIV Diagnosis & Treatment Breakdown Data by Type
    • 6.3 United States HIV Diagnosis & Treatment Breakdown Data by Application

    7 European Union

    • 7.1 European Union HIV Diagnosis & Treatment Breakdown Data by Company
    • 7.2 European Union HIV Diagnosis & Treatment Breakdown Data by Type
    • 7.3 European Union HIV Diagnosis & Treatment Breakdown Data by Application

    8 China

    • 8.1 China HIV Diagnosis & Treatment Breakdown Data by Company
    • 8.2 China HIV Diagnosis & Treatment Breakdown Data by Type
    • 8.3 China HIV Diagnosis & Treatment Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World HIV Diagnosis & Treatment Breakdown Data by Company
    • 9.2 Rest of World HIV Diagnosis & Treatment Breakdown Data by Type
    • 9.3 Rest of World HIV Diagnosis & Treatment Breakdown Data by Application
    • 9.4 Rest of World HIV Diagnosis & Treatment Breakdown Data by Countries
      • 9.4.1 Rest of World HIV Diagnosis & Treatment Sales by Countries
      • 9.4.2 Rest of World HIV Diagnosis & Treatment Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Abbott Laboratories
      • 10.1.1 Abbott Laboratories Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of HIV Diagnosis & Treatment
      • 10.1.4 HIV Diagnosis & Treatment Product Introduction
      • 10.1.5 Abbott Laboratories Recent Development
    • 10.2 Boehringer Ingelheim
      • 10.2.1 Boehringer Ingelheim Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of HIV Diagnosis & Treatment
      • 10.2.4 HIV Diagnosis & Treatment Product Introduction
      • 10.2.5 Boehringer Ingelheim Recent Development
    • 10.3 Bristol-Myers Squibb
      • 10.3.1 Bristol-Myers Squibb Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of HIV Diagnosis & Treatment
      • 10.3.4 HIV Diagnosis & Treatment Product Introduction
      • 10.3.5 Bristol-Myers Squibb Recent Development
    • 10.4 Cipla
      • 10.4.1 Cipla Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of HIV Diagnosis & Treatment
      • 10.4.4 HIV Diagnosis & Treatment Product Introduction
      • 10.4.5 Cipla Recent Development
    • 10.5 F. Hoffmann-La Roche
      • 10.5.1 F. Hoffmann-La Roche Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of HIV Diagnosis & Treatment
      • 10.5.4 HIV Diagnosis & Treatment Product Introduction
      • 10.5.5 F. Hoffmann-La Roche Recent Development
    • 10.6 Gilead
      • 10.6.1 Gilead Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of HIV Diagnosis & Treatment
      • 10.6.4 HIV Diagnosis & Treatment Product Introduction
      • 10.6.5 Gilead Recent Development
    • 10.7 GlaxoSmithKline
      • 10.7.1 GlaxoSmithKline Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of HIV Diagnosis & Treatment
      • 10.7.4 HIV Diagnosis & Treatment Product Introduction
      • 10.7.5 GlaxoSmithKline Recent Development
    • 10.8 Johnson & Johnson
      • 10.8.1 Johnson & Johnson Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of HIV Diagnosis & Treatment
      • 10.8.4 HIV Diagnosis & Treatment Product Introduction
      • 10.8.5 Johnson & Johnson Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 HIV Diagnosis & Treatment Sales Channels
      • 11.2.2 HIV Diagnosis & Treatment Distributors
    • 11.3 HIV Diagnosis & Treatment Customers

    12 Market Forecast

    • 12.1 Global HIV Diagnosis & Treatment Sales and Revenue Forecast 2019-2025
    • 12.2 Global HIV Diagnosis & Treatment Sales Forecast by Type
    • 12.3 Global HIV Diagnosis & Treatment Sales Forecast by Application
    • 12.4 HIV Diagnosis & Treatment Forecast by Regions
      • 12.4.1 Global HIV Diagnosis & Treatment Sales Forecast by Regions 2019-2025
      • 12.4.2 Global HIV Diagnosis & Treatment Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV.
      Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.
      In 2019, the market size of HIV Diagnosis & Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for HIV Diagnosis & Treatment.

      This report studies the global market size of HIV Diagnosis & Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the HIV Diagnosis & Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Abbott Laboratories
      Boehringer Ingelheim
      Bristol-Myers Squibb
      Cipla
      F. Hoffmann-La Roche
      Gilead
      GlaxoSmithKline
      Johnson & Johnson

      Market Segment by Product Type
      ELISA Test
      Saliva Tests
      Viral Load Test
      Western Blot
      Others

      Market Segment by Application
      Hospitals
      Clinics

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the HIV Diagnosis & Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key HIV Diagnosis & Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of HIV Diagnosis & Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now